William West, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Johns Hopkins University
Medical School
University of Tennessee
Residency
American Board of Internal Medicine - Oncology
TN State Medical License: 1974 - 2017
American Board of Internal Medicine: Internal Medicine
American Board of Internal Medicine: Medical Oncology
Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy ...
Schilsky, R.L., Levin, J., West, W.H., Wong, A., Colwell, B., Thirlwell, M.P., Ansari, R.H., Bell, W.N., White, R.L., Yates, B.B., McGuirt, P.V., Pazdur, R.; J Clin Oncol. 2002 Mar 15.
See more >>High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast.
Schwartzberg L, Weaver C, Lewkow L, McAneny B, Zhen B, Birch R, West W, Tauer K, Buckner C; Bone Marrow Transplant.. 1999-11-01.
See more >>High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma.
Weaver CH, Schwartzberg L, Rhinehart S, West J, Zhen B, West WH, Buckner CD; Bone Marrow Transplant.. 1998-02-01.
See more >>